Literature DB >> 12587686

Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults.

A F Walker1, R Bundy, S M Hicks, R W Middleton.   

Abstract

There is preliminary clinical evidence to support the contention that the anti-inflammatory and analgesic properties of bromelain help to reduce symptoms of osteo- and rheumatoid arthritis. However, there have been no controlled studies of its effects on joint health in healthy subjects who lack such diagnosis. The current study investigated the effects of bromelain on mild acute knee pain of less than 3 months duration in otherwise healthy adults. The study was an open, dose-ranging postal study in volunteers who had been recruited through newspaper and magazine articles. Two validated questionnaires (WOMAC knee health Index and the Psychological Well-Being Index) were completed at baseline and after one month's intervention with bromelain, randomly allocated to volunteers as either 200 mg or 400 mg per day. Seventy seven subjects completed the study. In both treatment groups, all WOMAC symptom dimension scores were significantly reduced compared with baseline, with reductions in the final battery (total symptom score) of 41 and 59% (P = 0.0001 and <0.0001) in the low and high dose groups respectively. In addition, improvements in total symptom score (P = 0.036) and the stiffness (P = 0.026) and physical function (P = 0.021) dimensions were significantly greater in the high-dose (400 mg per day) compared with the low-dose group. Compared to baseline, overall psychological well-being was significantly improved in both groups after treatment (P = 0.015 and P = 0.0003 in the low and high dose groups respectively), and again, a significant dose-response relationship was observed. We conclude that bromelain may be effective in ameliorating physical symptoms and improving general well-being in otherwise healthy adults suffering from mild knee pain in a dose-dependant manner. Double blind, placebo-controlled studies are now warranted to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12587686     DOI: 10.1078/094471102321621269

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

2.  Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis.

Authors:  Thitima Kasemsuk; Nadhaporn Saengpetch; Nathawut Sibmooh; Supeenun Unchern
Journal:  Clin Rheumatol       Date:  2016-07-28       Impact factor: 2.980

3.  Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.

Authors:  Temitope Samson Adu; Musa Vuyisile Mabandla
Journal:  Metab Brain Dis       Date:  2019-07-22       Impact factor: 3.584

4.  Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies.

Authors:  Sarah Brien; George Lewith; Ann Walker; Stephen M Hicks; Dick Middleton
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

5.  Ananas comosus Effect on Perineal Pain and Wound Healing After Episiotomy: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Samira Golezar
Journal:  Iran Red Crescent Med J       Date:  2016-03-01       Impact factor: 0.611

6.  Anti-arthritic potential of ethanol and aqueous extracts of stem bark of Cleistopholis patens on complete Freund's adjuvant-induced rheumatoid arthritis in rats.

Authors:  C Aloke; U A Ibiam; O U Orji; E I Ugwuja; N N Ezeani; P M Aja; N A Obasi
Journal:  J Ayurveda Integr Med       Date:  2019-10-09

7.  Comparative efficacy of bromelain and aceclofenac in limiting post-operative inflammatory sequelae in surgical removal of lower impacted third molar: a randomized controlled, triple blind clinical trial.

Authors:  Aishwarya Ashok Gupta; Rajanikanth Kambala; Nitin Bhola; Anendd Jadhav
Journal:  J Dent Anesth Pain Med       Date:  2022-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.